• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

November 9, 2015

5 Legal Uses for Medical Marijuana in Older Adults

Author(s):

Allison Gilchrist, Associate Editor

Despite lingering controversy around marijuana, the use of medical cannabis for various conditions is accepted across a wide spectrum of states.

Despite lingering controversy around marijuana, the use of medical cannabis for various conditions is accepted across a wide spectrum of states.

Kari L. Franson, PharmD, PhD, BCPP, of the University of Colorado Skaggs School of Pharmacy described the evidence for using medical marijuana in older patient populations during a session at the 2015 American Society of Consultant Pharmacists (ASCP) Annual Meeting and Exhibition in Las Vegas, Nevada.

Although many states have approved medical marijuana use for certain conditions, Franson reminded session attendees that “no product out there, pharmacological or otherwise, is without risk.”

Because marijuana is still a Schedule I controlled substance, handling and administering it in a pharmacy or hospital without some degree of approved protocol is considered a federal offense. Therefore, providers should err on the side of caution when dispensing cannabis.

Here is a list of conditions that can be legally treated with cannabis, though both patients and pharmacists should check their individual state regulations to see which conditions are approved in their state:

1. Cancer

Twenty-three states allow medical marijuana to be used as a treatment for cancer and cancer-related symptom relief.

Cannabis generally promotes appetite to curb the weight loss that may occur during chemotherapy, and it also acts as an agent to control chemo-related nausea and vomiting.

Dr. Franson said that medical marijuana “always performs poorer than oral megestrol acetate.”

2. Gastrointestinal disorders

Fifteen states allow providers to treat patients with Crohn’s disease or other gastrointestinal disorders such as inflammatory bowel disease (IBD) with medical marijuana to alleviate pain.

Even the Crohn’s & Colitis Foundation of America Patient Education Committee released a statement in January 2012 that said, “IBD patients have been found to have higher levels of cannabinoid receptors in their colonic tissue. Several small studies have shown that a significant portion of patients with IBD report smoking marijuana to relieve IBD-related syndromes.”

The organization stopped short of endorsing marijuana smoking by IBD patients.

3. Muscle spasticity

Currently, 22 states allow medical marijuana to be used to treat patients with muscle spasticity issues.

“The slow reaction time associated with marijuana is actually helpful in treating diseases with spasticity issues, like multiple sclerosis,” Dr. Franson explained.

It’s also noteworthy that 24 different states allow the use of medical marijuana to treat patients, primarily children, with epilepsy and seizure disorders.

Most data relate to pediatric refractory epilepsies.

“Nobody is really suggesting we use cannabis for adults having seizures,” Dr. Franson said. “Evidence shows seizure exacerbation after discontinuation.”

4. Glaucoma

Twenty-one states allow medical marijuana to be used for glaucoma, for which it has been a treatment since the 1970s.

Systemic administration of cannabis decreases intraocular pressure by 30%, though Dr. Franson explained that this effect might not last.

“Patients appear to develop a tolerance, but there may still be neuroprotective effects,” she said.

As Jeanette Wick, RPh, MBA, FASCP, previously noted, “In the medical community, however, the general consensus is that conventional therapies for reducing intraocular pressure outperform cannabinoids.”

The American Academy of Opthalmology stated in 2014 that it does not recommend marijuana or other cannabis products for the treatment of glaucoma.

5. Cachexia

In 1992, the FDA approved the use of dronabinol, a synthetic delta-9- tetrahydrocannabinol, as a treatment for the loss of appetite from HIV/AIDS-related cachexia. Currently, 21 states permit the use of medical marijuana as a cachexia treatment.

Cachexia is common among older adults because it can be linked to bedrest, which many older patients are confined to toward the end of life.

Bedrest decreases cytokine production, which creates a proinflammatory state and can lead to cachexia and reduced circulating antibodies.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Related Content
Advertisement
Streptococcus Pneumoniae Bacteria
June 30th 2025

21-Valent Pneumococcal Conjugate Vaccine Exhibits Consistent Safety and Immunogenicity Across Manufacturing Lots

Luke Halpern, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Woman with dry mouth -- Image credit: Rafael Ben-Ari | stock.adobe.com
June 28th 2025

Help Patients Prevent and Treat Dry Mouth

Jennifer Gershman, PharmD, CPh, PACS
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Medical Misinformation Affects Public Understanding of Long COVID
June 27th 2025

Medical Misinformation Affects Public Understanding of Long COVID

Camille Cabas, PharmD
Biosimilars -- Image credit: Shutter2U | stock.adobe.com
June 27th 2025

Correct Patient Misconceptions Around Biosimilars

Anjeza Fero, PharmD, RPh
Related Content
Advertisement
Streptococcus Pneumoniae Bacteria
June 30th 2025

21-Valent Pneumococcal Conjugate Vaccine Exhibits Consistent Safety and Immunogenicity Across Manufacturing Lots

Luke Halpern, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Woman with dry mouth -- Image credit: Rafael Ben-Ari | stock.adobe.com
June 28th 2025

Help Patients Prevent and Treat Dry Mouth

Jennifer Gershman, PharmD, CPh, PACS
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Medical Misinformation Affects Public Understanding of Long COVID
June 27th 2025

Medical Misinformation Affects Public Understanding of Long COVID

Camille Cabas, PharmD
Biosimilars -- Image credit: Shutter2U | stock.adobe.com
June 27th 2025

Correct Patient Misconceptions Around Biosimilars

Anjeza Fero, PharmD, RPh
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.